JITC

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
Nicholas D. Klemen, Melinda Wang, Jill C. Rubinstein, Kelly Olino, James Clune, Stephan Ariyan, Charles Cha, Sarah A. Weiss, Harriet M. Kluger, Mario Sznol

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000341; DOI: 10.1136/jitc-2019-000341
Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype
Hongliang Dong, Yueyao Yang, Chenhui Gao, Hehe Sun, Hongmin Wang, Chao Hong, Jun Wang, Fangyuan Gong, Xiaoming Gao

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000339; DOI: 10.1136/jitc-2019-000339
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Laura-Sophie Landwehr, Barbara Altieri, Jochen Schreiner, Iuliu Sbiera, Isabel Weigand, Matthias Kroiss, Martin Fassnacht, Silviu Sbiera

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000469; DOI: 10.1136/jitc-2019-000469
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000301; DOI: 10.1136/jitc-2019-000301
Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay
Diego A Lema, Ewa Jankowska-Gan, Nan Sethakorn, William Burlingham, Ticiana Leal

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000152; DOI: 10.1136/jitc-2019-000152
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103⁺ conventional dendritic cells
Yifan Zhou, Natalie Slone, Taylor T Chrisikos, Oleksandr Kyrysyuk, Rachel L Babcock, Yusra B Medik, Haiyan S Li, Eugenie S Kleinerman, Stephanie S Watowich

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000474; DOI: 10.1136/jitc-2019-000474
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
Charles Dolladille, Stephane Ederhy, Stéphane Allouche, Querntin Dupas, Radj Gervais, Jeannick Madelaine, Marion Sassier, Anne-Flore Plane, Francois Comoz, Ariel Aron Cohen, Franck Roland Thuny, Jennifer Cautela, Joachim Alexandre

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000261; DOI: 10.1136/jitc-2019-000261
Overcoming hypoxia-induced functional suppression of NK cells
Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Benjamin Wolfson, Fabiola Cecchi, Todd Hembrough, Stephen C Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, James W Hodge

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000246; DOI: 10.1136/jitc-2019-000246
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li, Yuqiao Sheng, Weizhou Hou, Padma Sampath, Daniel Byrd, Stephen Thorne, Yi Zhang

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000131; DOI: 10.1136/jitc-2019-000131
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
Laura Arribillaga, Iciar Echeverria, Viriginia Belsue, Timothy Gomez, Teresa Lozano, Noelia Casares, Lorea Villanueva, Sonia Domingos-Pereira, Pedro J Romero, Denise Nardelli-Haefliger, Sandra Hervás-Stubbs, Pablo Sarobe, María Josefa Rodriguez, José L Carrascosa, Thomas Zürcher, Juan José Lasarte

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000704; DOI: 10.1136/jitc-2020-000704

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages